Literature DB >> 6654640

Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys.

M Barza, A Kane, J Baum.   

Abstract

Although intravitreal injection of antibiotics is being used more widely in treatment of bacterial endophthalmitis, the pharmacokinetic principles that underlie such therapy have been derived exclusively from experiments in the rabbit. Therefore, we studied several representative antibiotics in normal eyes of rhesus monkeys. Carbenicillin (1,000 micrograms), cefazolin (1,000 micrograms), or gentamicin (100 micrograms) was injected intravitreally. Vitreous and aqueous humors were aspirated at intervals up to 96 hours after injection. The half-life values in the vitreous humor were: carbenicillin 10 hours, cefazolin 7 hours, and gentamicin 33 hours. Concomitant intraperitoneal administration of probenecid prolonged the vitreal half-life of carbenicillin to 20 hours and of cefazolin to 30 hours. The estimated vitreous volumes in these monkeys were approximately 3.0-4.0 ml. These results are consistent with the hypothesis that, in primates as in rabbits, beta-lactam antibiotics are eliminated via the retinal route and the aminoglycoside via the anterior route. This supports the applicability of the rabbit model to the treatment of endophthalmitis in humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6654640

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  A renal-like organic anion transport system in the ciliary epithelium of the bovine and human eye.

Authors:  Jonghwa Lee; Mohammad Shahidullah; Adam Hotchkiss; Miguel Coca-Prados; Nicholas A Delamere; Ryan M Pelis
Journal:  Mol Pharmacol       Date:  2015-02-06       Impact factor: 4.436

Review 2.  Inner blood-retinal barrier transporters: role of retinal drug delivery.

Authors:  Ken-ichi Hosoya; Masanori Tachikawa
Journal:  Pharm Res       Date:  2009-07-01       Impact factor: 4.200

3.  Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits.

Authors:  M H Miller; A Madu; G Samathanam; D Rush; C N Madu; K Mathisson; M Mayers
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

4.  Solution formulation development of a VEGF inhibitor for intravitreal injection.

Authors:  Michelle T Marra; Penney Khamphavong; Peter Wisniecki; Hovhannes J Gukasyan; Katsuhiko Sueda
Journal:  AAPS PharmSciTech       Date:  2011-02-11       Impact factor: 3.246

5.  Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells.

Authors:  Pradeep K Karla; Ravinder Earla; Sagar H Boddu; Thomas P Johnston; Dhananjay Pal; Ashim Mitra
Journal:  Curr Eye Res       Date:  2009-01       Impact factor: 2.424

6.  Intravenous cefazolin in penetrating eye injuries. I. Effects of trauma and multiple doses on intraocular delivery.

Authors:  D V Alfaro; P E Liggett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

7.  Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.

Authors:  W Liu; Q F Liu; R Perkins; G Drusano; A Louie; A Madu; U Mian; M Mayers; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor.

Authors:  Gangadhar Sunkara; Surya P Ayalasomayajula; Jack DeRuiter; Uday B Kompella
Journal:  Brain Res Bull       Date:  2009-09-15       Impact factor: 4.077

9.  Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits.

Authors:  M Mayers; D Rush; A Madu; M Motyl; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

10.  Pharmacokinetic behavior of intravitreal triamcinolone acetonide prepared by a hospital pharmacy.

Authors:  Masako Oishi; Shinichiro Maeda; Noriyasu Hashida; Nobuyuki Ohguro; Yasuo Tano; Nobuo Kurokawa
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.